Back to 
WELLINGTON MANAGEMENT GROUP LLP
WELLINGTON MANAGEMENT GROUP LLP
CTMX2 quarters
Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in CYTOMX THERAPEUTICS INC.
WELLINGTON MANAGEMENT GROUP LLP holds 5.2M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $19.4M as of 2026-Q2. The position was increased (+44.3% shares). CTMX represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$19.4M
Current Shares
5.2M
Total Value Change
+$2.5M
Total Shares Change
+1.6M
Quarter-by-Quarter History
Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS